BioWorld 2025年12月29日

Fortvita Biologics发现新型GLP-1R激动剂

Infographics: Dynamic digital data analysis Infographics: Dynamic digital data analysis Breaking News: BioWorld Science 2025 Year in Review » Fortvita Biologics discovers new GLP-1R agonists Fortvita Biologics discovers new GLP-1R agonists Fortvita Biologics Inc. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of autoimmune diseases, cardiovascular disorders, inflammatory disorders, diabetes, lung diseases, neurological disorders, obesity and renal disorders, among others. Researchers discover how glioblastoma tumors dodge chemotherapy Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers... Shionogi nabs revenue-generating ALS drugs with .5B Tanabe pact Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a .5 billion acquisition deal with... Big pharma taps fast Asia innovation in search of next Keytruda Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),... Infographics: Dynamic digital data analysis Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development ::